Revision of In Silico Toxicology (Switzerland)

{{DISPLAYTITLE:In Silico Toxicology (Switzerland)}}
BioNTech SE ( bee-ON-tek; or  bye-ON-tek  short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger ribonucleic acid (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer.<small> from [https://en.wikipedia.org/wiki/BioNTech Wikipedia]</small>

{{SF|
{{Twt|insilicotox}}
{{Wb|https://www.in-silico.ch/|in-silico.ch}}
}}
{{IDF|
{{Wd|Q30257020}}
}}

{{VHID|84672826697}}{{#subtitle: <big>company in Basel, Switzerland</big>}}